Prähypertonie - eine Grenzwertbestimmung

Schlüsselwörter

Hypertonie - Prähypertonie - Grenzwerte

Key words

hypertension - pre-hypertension - targets

Literatur

• 1 Chobanian A V, Bakris G L, Black H R. et al . The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC7 report.  JAMA. 2003;  289 2560-2572 ,  [Erratum JAMA 2003;290:197]
• 2 Domanski M, Mitchell G, Pfeffer M, Neaton J D, Norman J, Svendsen K, Grimm R, Cohen J, Stamler J. MRFIT Research Group . Pulse Pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT).  JAMA. 2002;  287 2677-2683
• 3 Julius S, Nesbitt S D, Egan B M, Weber M A, Michelson E L, Kaciroti N, Black H R, Grimm R H, Messerli F H, Oparil S, Schork M A. Trial of Preventing Hypertension (TROPHY) Study Investigators . Feasibility of treating prehypertension with an angiotensin-receptor blocker.  N Engl J Med. 2006;  354 1685-1697
• 4 Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.  Lancet. 2002;  360 1903-1913
• 5 Schunkert H. Pharmacotherapy for prehypertension - mission accomplished?.  N Engl J Med. 2006;  354 1742-1744
• 6 Svetkey L P. Management of prehypertension.  Hypertension. 2005;  45 1056-1061
• 7 Vasan R S, Larson M G, Leip E P. et al . Impact of high-normal blood pressure on the risk of cardiovascular disease.  N Engl J Med. 2001;  345 1291-1297
• 8 Wolf-Maier K, Cooper R S, Banegas J R, Giampaoli S, Hense H W, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.  JAMA. 2003;  289 2363-2369